The BoD of Sopharma postponed the EGM, initially scheduled for 16 October, to 30 October, according to an invitation currently pending approval in the Commercial Register. The agenda includes a proposal to distribute a DPS of EUR 0.052 (EUR 28m in total), the same amount approved by the AGM in June. If approved, this would imply a dividend yield of approximately 4.1%, based on the latest closing price of EUR 2.52. The date change is most likely related to the delay in the Commercial Register’s official entry of the invitation.